Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with advanced ovarian cancer, primary peritoneal cancer, or fallopian tube cancer of a specific type (serous or endometrioid), confirmed by a lab test — certain types such as clear cell, mucinous, and carcinosarcoma are not included
- Your cancer has continued to grow or spread after previous treatment, shown by scans, and you have at least one area of cancer that can be measured and has not been treated with radiation before
- You are generally able to carry out daily activities with little to no limitation (confirm with trial site for exact fitness level required)
- Your heart, liver, kidneys, and blood counts are working well enough to meet the trial's health requirements (confirm with trial site for exact values)
- Your cancer is classified as "platinum-resistant," meaning it stopped responding to platinum-based chemotherapy within a certain time period (confirm with trial site for exact definition)
Who may not be able to join:
- You have had a major surgery or serious physical injury within the 4 weeks before starting the trial
- You have had a severe allergic reaction to antibody-based treatments, doxorubicin (a type of chemotherapy), or any ingredient used in the trial treatments
- You currently have another cancer that is growing or needs active treatment
- You have cancer that has spread to your brain or the lining around your brain and it has not been treated or is still active (confirm with trial site for specific details)
- You have an uncontrolled infection, including HIV, hepatitis B, or hepatitis C, or a condition that weakens your immune system
- You have a moderate to large build-up of fluid in your abdomen (confirm with trial site for exact definition)
- You have had a bowel blockage in the last 3 months, or you currently need to receive nutrition directly into your veins
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trial Management, Regeneron Pharmaceuticals
Phone: 844-734-6643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 by investigator assessment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.